44 reports of this reaction
14.7% of all ACETAMINOPHEN AND IBUPROFEN reports
#1 most reported adverse reaction
DRUG INEFFECTIVE is the #1 most commonly reported adverse reaction for ACETAMINOPHEN AND IBUPROFEN, manufactured by AFT Pharmaceuticals US, Inc.. There are 44 FDA adverse event reports linking ACETAMINOPHEN AND IBUPROFEN to DRUG INEFFECTIVE. This represents approximately 14.7% of all 299 adverse event reports for this drug.
Patients taking ACETAMINOPHEN AND IBUPROFEN who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is a frequently reported adverse event for ACETAMINOPHEN AND IBUPROFEN, accounting for a significant proportion of all reports.
In addition to drug ineffective, the following adverse reactions have been reported for ACETAMINOPHEN AND IBUPROFEN:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 44 FDA reports for ACETAMINOPHEN AND IBUPROFEN. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 14.7% of all adverse event reports for ACETAMINOPHEN AND IBUPROFEN, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking ACETAMINOPHEN AND IBUPROFEN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.